nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—AR—scrotum—urinary bladder cancer	0.104	0.304	CbGeAlD
Nandrolone decanoate—AR—penis—urinary bladder cancer	0.0467	0.137	CbGeAlD
Nandrolone decanoate—Local reaction—Valrubicin—urinary bladder cancer	0.0265	0.0764	CcSEcCtD
Nandrolone decanoate—Oligospermia—Gemcitabine—urinary bladder cancer	0.0204	0.0589	CcSEcCtD
Nandrolone decanoate—Azoospermia—Thiotepa—urinary bladder cancer	0.0189	0.0544	CcSEcCtD
Nandrolone decanoate—Azoospermia—Gemcitabine—urinary bladder cancer	0.0159	0.0458	CcSEcCtD
Nandrolone decanoate—Azoospermia—Cisplatin—urinary bladder cancer	0.0148	0.0427	CcSEcCtD
Nandrolone decanoate—CYP19A1—prostate gland—urinary bladder cancer	0.0126	0.037	CbGeAlD
Nandrolone decanoate—MAOB—prostate gland—urinary bladder cancer	0.0119	0.0348	CbGeAlD
Nandrolone decanoate—AR—prostate gland—urinary bladder cancer	0.0112	0.0327	CbGeAlD
Nandrolone decanoate—Oligospermia—Methotrexate—urinary bladder cancer	0.0104	0.0301	CcSEcCtD
Nandrolone decanoate—Irritability—Valrubicin—urinary bladder cancer	0.0102	0.0293	CcSEcCtD
Nandrolone decanoate—MAOA—prostate gland—urinary bladder cancer	0.0101	0.0297	CbGeAlD
Nandrolone decanoate—MAOB—seminal vesicle—urinary bladder cancer	0.01	0.0294	CbGeAlD
Nandrolone decanoate—Oligospermia—Epirubicin—urinary bladder cancer	0.00976	0.0282	CcSEcCtD
Nandrolone decanoate—AR—seminal vesicle—urinary bladder cancer	0.00944	0.0277	CbGeAlD
Nandrolone decanoate—Oligospermia—Doxorubicin—urinary bladder cancer	0.00903	0.0261	CcSEcCtD
Nandrolone decanoate—MAOA—seminal vesicle—urinary bladder cancer	0.00857	0.0251	CbGeAlD
Nandrolone decanoate—AR—epithelium—urinary bladder cancer	0.0082	0.0241	CbGeAlD
Nandrolone decanoate—Azoospermia—Methotrexate—urinary bladder cancer	0.00811	0.0234	CcSEcCtD
Nandrolone decanoate—MAOB—renal system—urinary bladder cancer	0.00809	0.0237	CbGeAlD
Nandrolone decanoate—MAOB—urethra—urinary bladder cancer	0.00795	0.0233	CbGeAlD
Nandrolone decanoate—AR—smooth muscle tissue—urinary bladder cancer	0.00791	0.0232	CbGeAlD
Nandrolone decanoate—AR—renal system—urinary bladder cancer	0.00761	0.0223	CbGeAlD
Nandrolone decanoate—Azoospermia—Epirubicin—urinary bladder cancer	0.00759	0.0219	CcSEcCtD
Nandrolone decanoate—Local reaction—Fluorouracil—urinary bladder cancer	0.00758	0.0219	CcSEcCtD
Nandrolone decanoate—AR—urethra—urinary bladder cancer	0.00748	0.0219	CbGeAlD
Nandrolone decanoate—Azoospermia—Doxorubicin—urinary bladder cancer	0.00702	0.0203	CcSEcCtD
Nandrolone decanoate—MAOA—renal system—urinary bladder cancer	0.0069	0.0202	CbGeAlD
Nandrolone decanoate—CYP19A1—female reproductive system—urinary bladder cancer	0.00688	0.0202	CbGeAlD
Nandrolone decanoate—MAOA—urethra—urinary bladder cancer	0.00678	0.0199	CbGeAlD
Nandrolone decanoate—MAOB—female reproductive system—urinary bladder cancer	0.00648	0.019	CbGeAlD
Nandrolone decanoate—AR—female reproductive system—urinary bladder cancer	0.00609	0.0179	CbGeAlD
Nandrolone decanoate—MAOB—vagina—urinary bladder cancer	0.00586	0.0172	CbGeAlD
Nandrolone decanoate—Amenorrhoea—Thiotepa—urinary bladder cancer	0.00578	0.0167	CcSEcCtD
Nandrolone decanoate—Ethynodiol—ESR1—urinary bladder cancer	0.00557	0.298	CrCbGaD
Nandrolone decanoate—MAOA—female reproductive system—urinary bladder cancer	0.00553	0.0162	CbGeAlD
Nandrolone decanoate—AR—vagina—urinary bladder cancer	0.00551	0.0162	CbGeAlD
Nandrolone decanoate—Furunculosis—Methotrexate—urinary bladder cancer	0.00514	0.0148	CcSEcCtD
Nandrolone decanoate—MAOA—vagina—urinary bladder cancer	0.005	0.0147	CbGeAlD
Nandrolone decanoate—Fluid retention—Thiotepa—urinary bladder cancer	0.00482	0.0139	CcSEcCtD
Nandrolone decanoate—Furunculosis—Epirubicin—urinary bladder cancer	0.00481	0.0139	CcSEcCtD
Nandrolone decanoate—Norgestimate—ESR1—urinary bladder cancer	0.00473	0.254	CrCbGaD
Nandrolone decanoate—Furuncle—Methotrexate—urinary bladder cancer	0.00445	0.0129	CcSEcCtD
Nandrolone decanoate—Furunculosis—Doxorubicin—urinary bladder cancer	0.00445	0.0128	CcSEcCtD
Nandrolone decanoate—Furuncle—Epirubicin—urinary bladder cancer	0.00417	0.012	CcSEcCtD
Nandrolone decanoate—Etonogestrel—ESR1—urinary bladder cancer	0.0041	0.219	CrCbGaD
Nandrolone decanoate—Fluid retention—Gemcitabine—urinary bladder cancer	0.00405	0.0117	CcSEcCtD
Nandrolone decanoate—CYP19A1—lymph node—urinary bladder cancer	0.00403	0.0118	CbGeAlD
Nandrolone decanoate—Furuncle—Doxorubicin—urinary bladder cancer	0.00386	0.0111	CcSEcCtD
Nandrolone decanoate—Hypertension—Mitomycin—urinary bladder cancer	0.00381	0.011	CcSEcCtD
Nandrolone decanoate—MAOB—lymph node—urinary bladder cancer	0.00379	0.0111	CbGeAlD
Nandrolone decanoate—Fluid retention—Cisplatin—urinary bladder cancer	0.00378	0.0109	CcSEcCtD
Nandrolone decanoate—Pruritus—Valrubicin—urinary bladder cancer	0.0037	0.0107	CcSEcCtD
Nandrolone decanoate—Local reaction—Epirubicin—urinary bladder cancer	0.00369	0.0107	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptors—ESR2—urinary bladder cancer	0.00363	0.0123	CbGpPWpGaD
Nandrolone decanoate—Oedema—Mitomycin—urinary bladder cancer	0.0036	0.0104	CcSEcCtD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—ESR2—urinary bladder cancer	0.00358	0.0122	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—CYP4B1—urinary bladder cancer	0.00358	0.0122	CbGpPWpGaD
Nandrolone decanoate—AR—lymph node—urinary bladder cancer	0.00357	0.0105	CbGeAlD
Nandrolone decanoate—Hepatic function abnormal—Gemcitabine—urinary bladder cancer	0.00355	0.0102	CcSEcCtD
Nandrolone decanoate—Local reaction—Doxorubicin—urinary bladder cancer	0.00342	0.00987	CcSEcCtD
Nandrolone decanoate—Rash—Valrubicin—urinary bladder cancer	0.0033	0.00952	CcSEcCtD
Nandrolone decanoate—Dermatitis—Valrubicin—urinary bladder cancer	0.00329	0.00951	CcSEcCtD
Nandrolone decanoate—MAOA—lymph node—urinary bladder cancer	0.00323	0.00948	CbGeAlD
Nandrolone decanoate—Nausea—Valrubicin—urinary bladder cancer	0.00311	0.00897	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Epirubicin—urinary bladder cancer	0.003	0.00866	CcSEcCtD
Nandrolone decanoate—MAOA—Oxidative Stress—SOD2—urinary bladder cancer	0.003	0.0102	CbGpPWpGaD
Nandrolone decanoate—Irritability—Fluorouracil—urinary bladder cancer	0.00291	0.0084	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—ESR1—urinary bladder cancer	0.0029	0.155	CrCbGaD
Nandrolone decanoate—MAOA—Biological oxidations—GSTZ1—urinary bladder cancer	0.00288	0.0098	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.00287	0.00976	CbGpPWpGaD
Nandrolone decanoate—MAOA—Oxidative Stress—GPX1—urinary bladder cancer	0.00286	0.00973	CbGpPWpGaD
Nandrolone decanoate—Hyperlipidaemia—Epirubicin—urinary bladder cancer	0.00284	0.00819	CcSEcCtD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTZ1—urinary bladder cancer	0.00281	0.00955	CbGpPWpGaD
Nandrolone decanoate—Seborrhoeic dermatitis—Doxorubicin—urinary bladder cancer	0.00278	0.00801	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00277	0.00942	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Thiotepa—urinary bladder cancer	0.00277	0.00799	CcSEcCtD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—NCOR1—urinary bladder cancer	0.00277	0.00941	CbGpPWpGaD
Nandrolone decanoate—Irritability—Cisplatin—urinary bladder cancer	0.00276	0.00796	CcSEcCtD
Nandrolone decanoate—MAOA—Biological oxidations—GSTO2—urinary bladder cancer	0.00273	0.00929	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—NAT1—urinary bladder cancer	0.00273	0.00929	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTO2—urinary bladder cancer	0.00266	0.00906	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—NAT1—urinary bladder cancer	0.00266	0.00906	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00263	0.00893	CbGpPWpGaD
Nandrolone decanoate—Hyperlipidaemia—Doxorubicin—urinary bladder cancer	0.00262	0.00758	CcSEcCtD
Nandrolone decanoate—MAOA—Biological oxidations—UGT2B7—urinary bladder cancer	0.0025	0.00849	CbGpPWpGaD
Nandrolone decanoate—Dysphonia—Epirubicin—urinary bladder cancer	0.00248	0.00718	CcSEcCtD
Nandrolone decanoate—CYP19A1—Biological oxidations—UGT2B7—urinary bladder cancer	0.00244	0.00828	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.0024	0.00817	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—NAT2—urinary bladder cancer	0.00238	0.00811	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—NCOR1—urinary bladder cancer	0.00236	0.00804	CbGpPWpGaD
Nandrolone decanoate—Amenorrhoea—Epirubicin—urinary bladder cancer	0.00233	0.00672	CcSEcCtD
Nandrolone decanoate—Dysphonia—Doxorubicin—urinary bladder cancer	0.0023	0.00664	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.0023	0.00664	CcSEcCtD
Nandrolone decanoate—Rash—Mitomycin—urinary bladder cancer	0.00227	0.00656	CcSEcCtD
Nandrolone decanoate—Dermatitis—Mitomycin—urinary bladder cancer	0.00227	0.00655	CcSEcCtD
Nandrolone decanoate—MAOA—Biological oxidations—CYP4B1—urinary bladder cancer	0.00225	0.00765	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptors—ESR1—urinary bladder cancer	0.0022	0.00749	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP4B1—urinary bladder cancer	0.00219	0.00746	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—ATM—urinary bladder cancer	0.00219	0.00746	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—CDK4—urinary bladder cancer	0.00218	0.00742	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00216	0.00736	CbGpPWpGaD
Nandrolone decanoate—Amenorrhoea—Doxorubicin—urinary bladder cancer	0.00215	0.00622	CcSEcCtD
Nandrolone decanoate—Nausea—Mitomycin—urinary bladder cancer	0.00214	0.00618	CcSEcCtD
Nandrolone decanoate—MAOB—Alpha-synuclein signaling—SRC—urinary bladder cancer	0.00211	0.00719	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptors—PPARG—urinary bladder cancer	0.00201	0.00683	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Etoposide—urinary bladder cancer	0.00199	0.00574	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—ESR1—urinary bladder cancer	0.00196	0.00666	CbGpPWpGaD
Nandrolone decanoate—Gynaecomastia—Methotrexate—urinary bladder cancer	0.00195	0.00564	CcSEcCtD
Nandrolone decanoate—Fluid retention—Epirubicin—urinary bladder cancer	0.00194	0.0056	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.00193	0.00558	CcSEcCtD
Nandrolone decanoate—Hypertension—Thiotepa—urinary bladder cancer	0.00192	0.00553	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—HPGDS—urinary bladder cancer	0.00191	0.00648	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—GSTT1—urinary bladder cancer	0.00185	0.00629	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.0018	0.0052	CcSEcCtD
Nandrolone decanoate—Fluid retention—Doxorubicin—urinary bladder cancer	0.0018	0.00519	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.00174	0.00592	CbGpPWpGaD
Nandrolone decanoate—AR—FOXA1 transcription factor network—CREBBP—urinary bladder cancer	0.00172	0.00584	CbGpPWpGaD
Nandrolone decanoate—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.0017	0.0049	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Etoposide—urinary bladder cancer	0.00165	0.00477	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.00163	0.00556	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—CREBBP—urinary bladder cancer	0.00163	0.00554	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—RB1—urinary bladder cancer	0.00162	0.00552	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Gemcitabine—urinary bladder cancer	0.00161	0.00465	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00159	0.0054	CbGpPWpGaD
Nandrolone decanoate—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.00157	0.00454	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.00153	0.0052	CbGpPWpGaD
Nandrolone decanoate—Oedema—Gemcitabine—urinary bladder cancer	0.00152	0.0044	CcSEcCtD
Nandrolone decanoate—Irritability—Methotrexate—urinary bladder cancer	0.00151	0.00437	CcSEcCtD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—SRC—urinary bladder cancer	0.0015	0.00512	CbGpPWpGaD
Nandrolone decanoate—Oedema—Fluorouracil—urinary bladder cancer	0.0015	0.00433	CcSEcCtD
Nandrolone decanoate—MAOA—Biological oxidations—NAT2—urinary bladder cancer	0.0015	0.00509	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—CREBBP—urinary bladder cancer	0.00148	0.00503	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CCNE1—urinary bladder cancer	0.00146	0.00497	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—NAT2—urinary bladder cancer	0.00146	0.00496	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—SRC—urinary bladder cancer	0.00145	0.00492	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Thiotepa—urinary bladder cancer	0.00144	0.00416	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00144	0.00489	CbGpPWpGaD
Nandrolone decanoate—Oedema—Cisplatin—urinary bladder cancer	0.00142	0.0041	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—NCOR1—urinary bladder cancer	0.00142	0.00483	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Etoposide—urinary bladder cancer	0.00138	0.00397	CcSEcCtD
Nandrolone decanoate—Progesterone—ESR1—urinary bladder cancer	0.00137	0.0733	CrCbGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—urinary bladder cancer	0.00136	0.00463	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.00134	0.00456	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Thiotepa—urinary bladder cancer	0.00128	0.0037	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—GSTP1—urinary bladder cancer	0.00128	0.00436	CbGpPWpGaD
Nandrolone decanoate—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00126	0.00364	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.00125	0.00424	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.00124	0.00421	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.00121	0.0041	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.0012	0.00409	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—HPGDS—urinary bladder cancer	0.0012	0.00407	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Fluorouracil—urinary bladder cancer	0.00119	0.00344	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—GSTM1—urinary bladder cancer	0.00118	0.004	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.00117	0.00399	CbGpPWpGaD
Nandrolone decanoate—AR—FOXA1 transcription factor network—EP300—urinary bladder cancer	0.00117	0.00397	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—HPGDS—urinary bladder cancer	0.00117	0.00397	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—GSTT1—urinary bladder cancer	0.00116	0.00395	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CDKN2A—urinary bladder cancer	0.00116	0.00394	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.00115	0.00392	CbGpPWpGaD
Nandrolone decanoate—Rash—Thiotepa—urinary bladder cancer	0.00114	0.0033	CcSEcCtD
Nandrolone decanoate—Dermatitis—Thiotepa—urinary bladder cancer	0.00114	0.00329	CcSEcCtD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTT1—urinary bladder cancer	0.00113	0.00385	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Epirubicin—urinary bladder cancer	0.00111	0.00322	CcSEcCtD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—EP300—urinary bladder cancer	0.00111	0.00377	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Gemcitabine—urinary bladder cancer	0.00108	0.00311	CcSEcCtD
Nandrolone decanoate—Nausea—Thiotepa—urinary bladder cancer	0.00108	0.00311	CcSEcCtD
Nandrolone decanoate—Pruritus—Fluorouracil—urinary bladder cancer	0.00106	0.00306	CcSEcCtD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—HRAS—urinary bladder cancer	0.00106	0.0036	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—urinary bladder cancer	0.00106	0.00359	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.00105	0.00358	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.00103	0.00352	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Etoposide—urinary bladder cancer	0.00103	0.00298	CcSEcCtD
Nandrolone decanoate—Jaundice—Doxorubicin—urinary bladder cancer	0.00103	0.00298	CcSEcCtD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.00101	0.00343	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000997	0.00339	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000989	0.00285	CcSEcCtD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.000979	0.00333	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CCND1—urinary bladder cancer	0.000977	0.00333	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CREBBP—urinary bladder cancer	0.000977	0.00332	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—RB1—urinary bladder cancer	0.000973	0.00331	CbGpPWpGaD
Nandrolone decanoate—Rash—Gemcitabine—urinary bladder cancer	0.000961	0.00277	CcSEcCtD
Nandrolone decanoate—Dermatitis—Gemcitabine—urinary bladder cancer	0.00096	0.00277	CcSEcCtD
Nandrolone decanoate—Rash—Fluorouracil—urinary bladder cancer	0.000945	0.00273	CcSEcCtD
Nandrolone decanoate—Dermatitis—Fluorouracil—urinary bladder cancer	0.000944	0.00273	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—urinary bladder cancer	0.000931	0.00317	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000925	0.00267	CcSEcCtD
Nandrolone decanoate—Pruritus—Etoposide—urinary bladder cancer	0.000921	0.00266	CcSEcCtD
Nandrolone decanoate—Nausea—Gemcitabine—urinary bladder cancer	0.000905	0.00261	CcSEcCtD
Nandrolone decanoate—Rash—Cisplatin—urinary bladder cancer	0.000896	0.00259	CcSEcCtD
Nandrolone decanoate—Dermatitis—Cisplatin—urinary bladder cancer	0.000895	0.00258	CcSEcCtD
Nandrolone decanoate—Nausea—Fluorouracil—urinary bladder cancer	0.00089	0.00257	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—RHOA—urinary bladder cancer	0.000883	0.00301	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000856	0.00247	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—urinary bladder cancer	0.000845	0.00287	CbGpPWpGaD
Nandrolone decanoate—Nausea—Cisplatin—urinary bladder cancer	0.000844	0.00244	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000842	0.00286	CbGpPWpGaD
Nandrolone decanoate—Rash—Etoposide—urinary bladder cancer	0.00082	0.00237	CcSEcCtD
Nandrolone decanoate—Dermatitis—Etoposide—urinary bladder cancer	0.00082	0.00237	CcSEcCtD
Nandrolone decanoate—MAOA—Biological oxidations—GSTP1—urinary bladder cancer	0.000804	0.00273	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000793	0.0027	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—urinary bladder cancer	0.000787	0.00268	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTZ1—urinary bladder cancer	0.000785	0.00267	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTP1—urinary bladder cancer	0.000784	0.00267	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000779	0.00265	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000773	0.00263	CbGpPWpGaD
Nandrolone decanoate—Nausea—Etoposide—urinary bladder cancer	0.000773	0.00223	CcSEcCtD
Nandrolone decanoate—Hypertension—Epirubicin—urinary bladder cancer	0.000772	0.00223	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—urinary bladder cancer	0.000764	0.0026	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000754	0.00256	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTO2—urinary bladder cancer	0.000744	0.00253	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NAT1—urinary bladder cancer	0.000744	0.00253	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—GSTM1—urinary bladder cancer	0.000739	0.00251	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000736	0.0025	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000733	0.00249	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.00073	0.00248	CbGpPWpGaD
Nandrolone decanoate—Oedema—Epirubicin—urinary bladder cancer	0.000729	0.00211	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—urinary bladder cancer	0.000724	0.00246	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CCND1—urinary bladder cancer	0.000723	0.00246	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000721	0.00245	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000717	0.00244	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Doxorubicin—urinary bladder cancer	0.000714	0.00206	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000711	0.00242	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CDKN1A—urinary bladder cancer	0.000699	0.00238	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—PTEN—urinary bladder cancer	0.000697	0.00237	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.00069	0.00235	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—UGT2B7—urinary bladder cancer	0.00068	0.00231	CbGpPWpGaD
Nandrolone decanoate—Oedema—Doxorubicin—urinary bladder cancer	0.000675	0.00195	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—EP300—urinary bladder cancer	0.000665	0.00226	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—SRC—urinary bladder cancer	0.000647	0.0022	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000637	0.00217	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000635	0.00216	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000633	0.00215	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—urinary bladder cancer	0.000631	0.00215	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000631	0.00215	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.000628	0.00214	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000625	0.00213	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000623	0.00212	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Methotrexate—urinary bladder cancer	0.000619	0.00179	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—CYP4B1—urinary bladder cancer	0.000613	0.00208	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.00061	0.00208	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000607	0.00207	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000605	0.00206	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Epirubicin—urinary bladder cancer	0.000579	0.00167	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—SLC19A1—urinary bladder cancer	0.000579	0.00197	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—EGFR—urinary bladder cancer	0.000567	0.00193	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PRSS3—urinary bladder cancer	0.000564	0.00192	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Methotrexate—urinary bladder cancer	0.000551	0.00159	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.00055	0.00187	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000548	0.00187	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000546	0.00186	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Doxorubicin—urinary bladder cancer	0.000536	0.00155	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.00053	0.0018	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000524	0.00178	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Epirubicin—urinary bladder cancer	0.000516	0.00149	CcSEcCtD
Nandrolone decanoate—AR—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000495	0.00169	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000495	0.00168	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTZ1—urinary bladder cancer	0.000492	0.00168	CbGpPWpGaD
Nandrolone decanoate—Rash—Methotrexate—urinary bladder cancer	0.000491	0.00142	CcSEcCtD
Nandrolone decanoate—Dermatitis—Methotrexate—urinary bladder cancer	0.000491	0.00142	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metabolism—GSTZ1—urinary bladder cancer	0.00048	0.00163	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Doxorubicin—urinary bladder cancer	0.000477	0.00138	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000473	0.00161	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NAT1—urinary bladder cancer	0.000467	0.00159	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTO2—urinary bladder cancer	0.000467	0.00159	CbGpPWpGaD
Nandrolone decanoate—Nausea—Methotrexate—urinary bladder cancer	0.000463	0.00134	CcSEcCtD
Nandrolone decanoate—Rash—Epirubicin—urinary bladder cancer	0.00046	0.00133	CcSEcCtD
Nandrolone decanoate—Dermatitis—Epirubicin—urinary bladder cancer	0.000459	0.00133	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000457	0.00155	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NAT1—urinary bladder cancer	0.000455	0.00155	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTO2—urinary bladder cancer	0.000455	0.00155	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TYMP—urinary bladder cancer	0.000451	0.00153	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000448	0.00152	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000444	0.00151	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000437	0.00149	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000436	0.00148	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000434	0.00148	CbGpPWpGaD
Nandrolone decanoate—Nausea—Epirubicin—urinary bladder cancer	0.000433	0.00125	CcSEcCtD
Nandrolone decanoate—MAOA—Metabolism—UGT2B7—urinary bladder cancer	0.000427	0.00145	CbGpPWpGaD
Nandrolone decanoate—Rash—Doxorubicin—urinary bladder cancer	0.000426	0.00123	CcSEcCtD
Nandrolone decanoate—Dermatitis—Doxorubicin—urinary bladder cancer	0.000425	0.00123	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000425	0.00144	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—UGT2B7—urinary bladder cancer	0.000416	0.00142	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NAT2—urinary bladder cancer	0.000408	0.00139	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000407	0.00139	CbGpPWpGaD
Nandrolone decanoate—Nausea—Doxorubicin—urinary bladder cancer	0.000401	0.00116	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000393	0.00134	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000392	0.00133	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP4B1—urinary bladder cancer	0.000384	0.00131	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000383	0.0013	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.00038	0.00129	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000379	0.00129	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000379	0.00129	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP4B1—urinary bladder cancer	0.000375	0.00128	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000375	0.00128	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000375	0.00127	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.000371	0.00126	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC19A1—urinary bladder cancer	0.000363	0.00124	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000361	0.00123	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC19A1—urinary bladder cancer	0.000354	0.0012	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PRSS3—urinary bladder cancer	0.000354	0.0012	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—RRM2—urinary bladder cancer	0.000352	0.0012	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000351	0.00119	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.000351	0.00119	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PRSS3—urinary bladder cancer	0.000345	0.00117	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000345	0.00117	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.000327	0.00111	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HPGDS—urinary bladder cancer	0.000326	0.00111	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ENO2—urinary bladder cancer	0.000326	0.00111	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.00032	0.00109	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTT1—urinary bladder cancer	0.000316	0.00108	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.000315	0.00107	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.000312	0.00106	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000308	0.00105	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000304	0.00103	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.000302	0.00103	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.0003	0.00102	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.000293	0.000997	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000291	0.000989	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TYMP—urinary bladder cancer	0.000283	0.000962	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000277	0.000941	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TYMP—urinary bladder cancer	0.000276	0.000938	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000274	0.000933	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SMC1A—urinary bladder cancer	0.000274	0.000931	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.000268	0.000913	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000265	0.000901	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000263	0.000896	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NQO1—urinary bladder cancer	0.000263	0.000894	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000258	0.000879	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NAT2—urinary bladder cancer	0.000256	0.00087	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NAT2—urinary bladder cancer	0.000249	0.000849	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ESR2—urinary bladder cancer	0.000239	0.000811	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—RRM2—urinary bladder cancer	0.000221	0.000751	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTP1—urinary bladder cancer	0.000219	0.000745	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—RRM2—urinary bladder cancer	0.000215	0.000733	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.00021	0.000715	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ENO2—urinary bladder cancer	0.000204	0.000696	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HPGDS—urinary bladder cancer	0.000204	0.000696	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TYMS—urinary bladder cancer	0.000204	0.000693	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTM1—urinary bladder cancer	0.000201	0.000685	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NCOR1—urinary bladder cancer	0.000201	0.000685	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ENO2—urinary bladder cancer	0.000199	0.000678	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HPGDS—urinary bladder cancer	0.000199	0.000678	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTT1—urinary bladder cancer	0.000198	0.000675	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000198	0.000675	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTT1—urinary bladder cancer	0.000193	0.000658	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GPX1—urinary bladder cancer	0.000193	0.000656	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00019	0.000648	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ERCC2—urinary bladder cancer	0.000189	0.000644	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NCOR1—urinary bladder cancer	0.000184	0.000626	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—MTHFR—urinary bladder cancer	0.000178	0.000605	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ERCC2—urinary bladder cancer	0.000173	0.000589	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NQO1—urinary bladder cancer	0.000165	0.000561	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—HRAS—urinary bladder cancer	0.000161	0.000548	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NQO1—urinary bladder cancer	0.000161	0.000547	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000156	0.000532	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000156	0.000531	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ESR1—urinary bladder cancer	0.000145	0.000492	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PPARG—urinary bladder cancer	0.000144	0.000491	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CREBBP—urinary bladder cancer	0.000139	0.000472	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTP1—urinary bladder cancer	0.000137	0.000468	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000136	0.000463	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTP1—urinary bladder cancer	0.000134	0.000456	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PPARG—urinary bladder cancer	0.000132	0.000449	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.00013	0.000441	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TYMS—urinary bladder cancer	0.000128	0.000435	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—CREBBP—urinary bladder cancer	0.000127	0.000431	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NCOR1—urinary bladder cancer	0.000126	0.00043	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTM1—urinary bladder cancer	0.000126	0.00043	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TYMS—urinary bladder cancer	0.000125	0.000424	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NCOR1—urinary bladder cancer	0.000123	0.000419	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTM1—urinary bladder cancer	0.000123	0.000419	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GPX1—urinary bladder cancer	0.000121	0.000412	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ERCC2—urinary bladder cancer	0.000119	0.000404	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GPX1—urinary bladder cancer	0.000118	0.000401	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ERCC2—urinary bladder cancer	0.000116	0.000394	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS2—urinary bladder cancer	0.000114	0.000386	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MTHFR—urinary bladder cancer	0.000112	0.00038	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MTHFR—urinary bladder cancer	0.000109	0.00037	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTEN—urinary bladder cancer	9.9e-05	0.000337	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—EP300—urinary bladder cancer	9.44e-05	0.000321	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPARG—urinary bladder cancer	9.05e-05	0.000308	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPARG—urinary bladder cancer	8.83e-05	0.0003	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CREBBP—urinary bladder cancer	8.7e-05	0.000296	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CREBBP—urinary bladder cancer	8.48e-05	0.000289	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MYC—urinary bladder cancer	7.52e-05	0.000256	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS2—urinary bladder cancer	7.12e-05	0.000242	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS2—urinary bladder cancer	6.95e-05	0.000236	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTEN—urinary bladder cancer	6.21e-05	0.000211	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTEN—urinary bladder cancer	6.06e-05	0.000206	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—EP300—urinary bladder cancer	5.92e-05	0.000201	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—EP300—urinary bladder cancer	5.78e-05	0.000197	CbGpPWpGaD
